Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Importers Notice of Registration - 2017 > Importer of Controlled Substances Registration

Importers Notice of Registration - 2017

[Federal Register Volume 82, Number 224 (Wednesday, November 22, 2017)]
[Notices]
[Page 55639]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-25284]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Registration

ACTION: Notice of registration.


SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration as importers of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

Company FR Docket Published
Almac Clinical Services Incorp (ACSI) 82 FR 37114 August 8, 2017
Stepan Company 82 FR 41054 August 29, 2017
Fresenius Kabi USA, LLC 82 FR 41053 August 29, 2017
Cambrex Charles City 82 FR 41055 August 29, 2017
Spex Certiprep Group, LLC 82 FR 42120 September 6, 2017
Akorn, Inc 82 FR 42117 September 6, 2017
Fisher Clinical Services, Inc 82 FR 42121 September 6, 2017
Siegfried USA, LLC 82 FR 42117 September 6, 2017
Mylan Pharmaceuticals, Inc 82 FR 42120 September 6, 2017
KVK-Tech, Inc 82 FR 42119 September 6, 2017
Cerilliant Corporation 82 FR 43404 September 15, 2017
Unither Manufacturing LLC 82 FR 43571 September 18, 2017
Mylan Pharmaceuticals, Inc 82 FR 43572 September 18, 2017
Catalent Centers, LLC 82 FR 43569 September 18, 2017
Specgx LLC 82 FR 43571 September 18, 2017
Sharp Clinical Services, Inc 82 FR 43572 September 18, 2017
Cody Laboratories, Inc 82 FR 45612 September 29, 2017
Bellwyck Clinical Services 82 FR 45613 September 29, 2017

The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

Dated: November 16, 2017.

Demetra Ashley,
Acting Assistant Administrator.

[FR Doc. 2017-25284 Filed 11-21-17; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility